UK

AstraZeneca to shell out £12M in severance dispute with workers at former England plant
AstraZeneca to shell out £12M in severance dispute with workers at former England plant
Fierce Pharma
AstraZeneca
UK
Flag link:
NICE recommends funding for psoriasis and type 1 diabetes drugs
NICE recommends funding for psoriasis and type 1 diabetes drugs
Pharmaforum
NICE
UK
NHS
AbbVie
Skyrizi
AstraZeneca
Farxiga
Flag link:
U.K. launches subscription model to pay for antibiotics
U.K. launches subscription model to pay for antibiotics
BioCentury
UK
antibiotics
subscription model
Flag link:
How This Startup Is Applying Machine Learning To Disease Diagnosis
How This Startup Is Applying Machine Learning To Disease Diagnosis
Forbes
Feebris
UK
diagnostics
respiratory disease
artificial intelligence
machine learning
Flag link:
Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout
Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout
Endpoints
Spark Therapeutics
Roche
FTC
UK
M&A
Flag link:
BIO Roundup: Agenus, FDA, Merck’s Frazier and Much More
BIO Roundup: Agenus, FDA, Merck’s Frazier and Much More
BioSpace
Agenus
Jamie Dimon
BIO 2019
RWE
FDA
immuno-oncology
Merck
Ken Frazier
UK
Flag link:
Orkambi parents start ‘buyers club’ to import generic version of CF drug
Orkambi parents start ‘buyers club’ to import generic version of CF drug
Pharmaforum
cystic fibrosis
patients
UK
Orkambi
Vertex Pharmaceuticals
Flag link:
BI chief “regrets” Brexit, but continues to invest in UK
BI chief “regrets” Brexit, but continues to invest in UK
Pharmaforum
UK
Brexit
Boehringer Ingelheim
Flag link:
UK R&D Roundup: Pharma gets in on the biotech boom
UK R&D Roundup: Pharma gets in on the biotech boom
Pharmaforum
UK
Brexit
biotech
R&D
Flag link:
AstraZeneca's Imfinzi gets a lift in lung cancer from England's cost watchdogs
AstraZeneca's Imfinzi gets a lift in lung cancer from England's cost watchdogs
Fierce Pharma
AstraZeneca
Imfinzi
lung cancer
NICE
UK
Flag link:
Vertex destroys nearly 8,000 Orkambi packs amid U.K. pricing standoff
Vertex destroys nearly 8,000 Orkambi packs amid U.K. pricing standoff
Fierce Pharma
Vertex Pharmaceuticals
Orkambi
drug pricing
UK
Flag link:
As Brexit row become increasingly anarchic, is UK’s reputation with pharma suffering?
As Brexit row become increasingly anarchic, is UK’s reputation with pharma suffering?
Pharmaforum
Brexit
UK
Europe
Flag link:
Sanofi may airlift medicines into UK after Brexit
Sanofi may airlift medicines into UK after Brexit
Pharmaforum
Sanofi
UK
Europe
Brexit
vaccines
flu vaccines
Flag link:
Brexit delay offers biopharma more time to prepare for a no-deal
Brexit delay offers biopharma more time to prepare for a no-deal
BioCentury
Europe
UK
Brexit
drug shortages
Flag link:
UK biotech industry booms on record investment – analysis
UK biotech industry booms on record investment – analysis
Pharmaforum
UK
biotech
R&D
Flag link:
UK gets early access to Roche’s breast cancer immunotherapy
UK gets early access to Roche’s breast cancer immunotherapy
Pharmaforum
Roche
Tecentriq
Celgene
Abraxane
UK
triple-negative breast cancer
Flag link:
Pharma urges politicians to stop no-deal Brexit in today’s vote
Pharma urges politicians to stop no-deal Brexit in today’s vote
Pharmaforum
Brexit
UK
Europe
Flag link:
Vertex CEO, CCO head for U.K. hearing on Orkambi pricing standoff
Vertex CEO, CCO head for U.K. hearing on Orkambi pricing standoff
Fierce Pharma
Vertex Pharmaceuticals
drug pricing
cystic fibrosis
NHS
UK
Orkambi
Flag link:
It's not a Brexit problem, Sanofi says of epilepsy drug shortages
It's not a Brexit problem, Sanofi says of epilepsy drug shortages
Fierce Pharma
Sanofi
drug shortages
Brexit
UK
epilepsy
Epilim
Depakote
Flag link:
Brexit could disrupt medicine supplies for six months – minister
Brexit could disrupt medicine supplies for six months – minister
Pharmaforum
Brexit
UK
Europe
Flag link:

Pages